Accessibility Menu
Global Roundtable logo

Global Roundtable(OTC) GRCU

Market Cap$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-100%
5 Year-100%
1 Year-99%
1 Month+0%
$0.00
+0.00%
+0.00Today
Global Roundtable last closing stock price
MetricPriceDate
Last closeUSD 0.002026-09-04
Global Roundtable stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-27
1 month+0%USD 0.002026-08-03
3 month+0%USD 0.002026-06-05
Year to date-99.33%USD 0.002025-12-31
1 year-99%USD 0.002025-09-03
3 year-99.75%USD 0.002023-09-05
5 year-99.98%USD 0.002021-09-03
Since inception-100%USD 598,002,941.182006-07-14

Global Roundtable Financials at a Glance

Market Cap

$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.30M

Net Income (TTM)

-$243.23K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

14.23 (High)

Price

$0.00

Volume

1,248

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Nov 27, 2024

GRCU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Global Roundtable

Global Roundtable Corporation is a healthcare company focused on providing health and wellness services and products. Formerly known as Green Cures & Botanical Distribution Inc., the company rebranded in May 2023 and has been operational since 1986, based in Denver, Colorado.

Products and Services
  • Health and wellness products tailored for diverse consumer needs
  • Innovative services aimed at enhancing overall well-being
  • Research-driven solutions in the pharmaceutical sector
Growth Outlook
  • Recent quarterly revenue peaked at 25,477, indicating strong market interest
  • Gross profit margin improved to 68.8% in Q3 2024, showcasing operational efficiency
  • Positive cash flow from operations of 316,515 in Q2 2024 highlights financial resilience
Financial Highlights
  • Trailing twelve months (TTM) revenue of 160,87 reflects a growing business
  • Net income of -108,396 in Q4 2024 shows potential for recovery
  • Current ratio of 0.84 indicates manageable short-term liabilities
Global Roundtable Corporation operates in the medical and pharmaceutical industry, focusing on health and wellness. The company has shown promising growth, particularly in its recent quarterly performance, with a notable increase in revenue and gross profit margins. The transition to a new brand identity has positioned the company to capitalize on emerging market trends in health and wellness. The financial outlook appears cautiously optimistic, with a significant cash flow from operations in Q2 2024, suggesting that the company is effectively managing its resources. Despite facing challenges reflected in net income figures, the overall trajectory indicates potential for recovery and growth. Investors may find the company's commitment to innovation and efficiency appealing as it navigates the evolving healthcare landscape.
AI Generated • Aug 16, 2026

Industry

Personal Products

CEO

Robert Tanko

Headquarters

Denver, CO 80231, US

GRCU Financials

Key Financial Metrics (TTM)

Gross Margin

36.81%

Operating Margin

-17.40%

Net Income Margin

-18.71%

Return on Equity

-34.98%

Return on Capital

-21.98%

Return on Assets

-11.95%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.23B

Volume

1.25K

Avg. Volume

26.50K

Financials (TTM)

Gross Profit

$478.63K

Operating Income

-$226.28K

EBITDA

-$186.45K

Operating Cash Flow

$411.94K

Capital Expenditure

$2.00

Free Cash Flow

$411.94K

Cash & ST Invst.

$362.96K

Total Debt

$373.35K

Global Roundtable Performance Analysis

Global Roundtable annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 135,861N/A
20222022-12-31USD 102,083-24.9%
20232023-12-31USD 2,250,4022104.5%
20242024-12-31USD 1,300,267-42.2%
Global Roundtable sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-33.9%
Q22024-06-3048.6%
Q32024-09-30-96.6%
Q42024-12-31-36.9%
Global Roundtable annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.00N/A
20222022-12-31USD -0.000.0%
20232023-12-31USD 0.00N/A
20242024-12-31USD 0.00N/A
Global Roundtable sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12024-03-31-186.4%
Q22024-06-30184.0%
Q32024-09-30-143.5%
Q42024-12-31-0.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$16.09K

-97.9%

Gross Profit

$4.10K

-99.2%

Gross Margin

25.47%

N/A

Market Cap

$7.20KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$360.00

N/A

Employees

20

N/A

Net Income

-$108.40K

-137.6%

EBITDA

-$100.68K

-126.8%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Total Cash

$362.96K

+75.9%

Total Debt

$373.35K

+2.6%

Accounts Receivable

$767.26K

+37.4%

Inventory

$29.19K

-15.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$373.35K

+2.6%

Return on Assets

-11.95%

N/A

Return on Invested Capital

-34.49%

N/A

Free Cash Flow

-$13.65K

+96.0%

Operating Cash Flow

-$13.65K

+96.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GEATFRadiko Holdings Corp
$0.00+0.00%
XBRAFXebra Brands Ltd.
$0.00+0.00%
FITXCreative Edge Nutrition, Inc.
$0.00+0.00%
VRTHFIndigenous Bloom Hemp Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.15-0.12%
NVDANvidia
$230.36+0.01%
PATHUiPath
$15.19-0.17%
INTCIntel
$95.80+0.05%

Questions About GRCU

What is the current price of Global Roundtable?

Global Roundtable is trading at $0.00 per share.

What is the 52-week range for Global Roundtable?

Over the past 52 weeks, Global Roundtable has traded between $0.00 and $0.00.

How much debt does Global Roundtable have?

As of the most recent reporting period, Global Roundtable reported total debt of $373.35K.

How much cash does Global Roundtable have on hand?

Global Roundtable reported $362.96K in cash and cash equivalents in its most recent financial results.

What is Global Roundtable’s dividend yield?

Global Roundtable does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.